The chemical composition of the essential oil obtained by hydro-distillation method from the aerial parts of Leontopodium longifolium Ling was analyzed by gas chromatography-mass spectrometry (GC-MS). Totally, forty-three compounds constituting 96.90 % of the oil were detected. The predominant constituents in the oil were α-bisabolol (28.37 %) and α-bisabolol oxide B (10.66 %). The essential oil showed relatively low antioxidant activity (IC50 = 8.907 mg/ml) in the 2,2-diphenyl-1-picrylhydrazil (DPPH) radical scavenging assay, and showed weak antibacterial activity against Staphylococcus aureus, Bacillus subtilis and Pseudomonas aeruginosa with inhibition diameters from 11 mm to 13 mm in antimicrobial tests using disc agar diffusion method.
Phytochemical investigation of the roots of Leontopodium longifolium, led to the isolation of a novel norsesquiterpene, named as longifolactone (1), along with three known diterpenes. The structures of these compounds were elucidated by analysis of HR-ESI-MS, UV, IR and 1D and 2D NMR spectroscopic data. The absolute configuration of the new compound was determined by electronic circular dichroism (ECD) using both experimental and calculated ECD spectra. Furthermore, their anti-inflammatory effects were evaluated in LPS-activated RAW264.7 cells to determine their effects on the release of NO. Longifolactone (1) showed weak cytotoxicity towards two human cancer cell lines. GRAPHICAL ABSTRACT
A novel norsesquiterpene with rearranged triquinane skeleton, named as longifodiol (1), was isolated from the roots of Leontopodium longifolium. Its structure was elucidated by HR-ESI-MS, IR and NMR spectroscopic analyses, and the absolute configuration was determined by single crystal X-ray diffraction method. Longifodiol (1) showed moderate inhibitory activity on NO production in LPS-activated RAW264.7 cells.
Antimicrobial photodynamic therapy (aPDT) offers a promising non-antibiotic alternative for localized infections; however, its efficacy is frequently compromised by photosensitizer aggregation and rapid washout. Here, we report a bio-hybrid platform that combines the biopolymer chitosan with the biomineral hydroxyapatite to host methylene blue (MB) as a scaffold-associated photosensitizer. The resulting methylene blue-loaded chitosan/hydroxyapatite composite (MB@CS/HAp) was prepared by in situ mineralization and exhibited an effective retained MB loading of 1.2 wt%. Structural and physicochemical characterization confirmed successful composite formation and non-covalent MB incorporation. The CS/HAp scaffold exhibited a mesoporous structure with a BET specific surface area of 14.6 m2 g–1, providing a favorable host matrix that supports MB association and is designed to limit excessive self-aggregation while helping to preserve a more photoactive dispersed state.,Mass-balance and desorption studies indicated substantial MB retention, with a cumulative desorbed fraction of 27.8 ± 0.7% after 12 h under physiological conditions. Under the tested short-contact aPDT conditions, MB@CS/HAp achieved complete inhibition of Escherichia coli and Staphylococcus aureus at composite concentrations of 0.25 and 0.03 mg mL⁻1, respectively (at 15 J cm⁻2). When normalized to MB content, this corresponds to MB-equivalent MICs of 3.0 µg mL⁻1 for E. coli and 0.36 µg mL⁻1 for S. aureus, representing ~21-fold and ~11-fold reductions in the required MB dose relative to free MB. Molecular dynamics simulations showed that MB is stabilized at the CS/HAp interface via electrostatic and hydrogen-bonding interactions, resulting in reduced mobility and improved desorption resistance. These results together establish MB@CS/HAp as a biopolymer–biomineral, scaffold-associated photosensitizer platform and provide design guidance for localized solid-state aPDT materials.
10 October 2026 in European Journal of Medicinal Chemistry